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Background: Radical hysterectomy and radiotherapy have long been mainstays of cervical cancer treatment. Early
stage cervical cancer (FIGO stage IB1–IIA) is traditionally treated using radical surgery combined with radiotherapy,
while locally advanced cervical cancer is treated using radiotherapy alone or chemoradiotherapy. In this retrospective
study, we describe and analyse the presenting clinical features and outcomes in our cohort and evaluate possible risk
factors for postoperative morbidity in women who underwent surgery for chronic radiation enteropathy (CRE).
Methods: One hundred sixty-six eligible cervical cancer patients who underwent surgery for CRE were retrospectively
identified between September 2003 and July 2014 in a prospectively maintained database. Among them, 46 patients
received radical radiotherapy (RRT) and 120 received radical surgery plus radiotherapy (RS + RT). Clinical features,
postoperative morbidity and mortality, and risk factors for postoperative morbidity were analysed.
Results: RS + RT group patients were more likely to present with RTOG/EORTC grade III late morbidity (76.1 % vs 92.5 %;
p = 0.004), while RRT group patients tended to show RTOG/EORTC grade IV late morbidity (23.9 % vs 7.5 %; p = 0.004).
One hundred forty patients (84.3 %) were treated with aggressive resection (anastomosis 57.8 % and stoma 26.5 %).
Overall and major morbidity, mortality and incidence of reoperation in the RRT and RS + RT groups did not differ
significantly (63 % vs 64.2 % [p = 1.000], 21.7 % vs 11.7 % [p = 0.137], 6.5 % vs 0.8 % [p = 0.065] and 6.5 % vs 3.3 %
[p = 0.360], respectively). However, incidence of permanent stoma and mortality during follow-up was higher in
the RRT group than in the RS + RT group (44.2 % vs 12.6 % [p = 0.000] and 16.3 % vs 3.4 % [p = 0.004], respectively). In
multivariate analysis, preoperative anaemia was significantly associated with overall morbidity (p = 0.015), while severe
intra-abdominal adhesion (p = 0.017), ASA grades III–V (P = 0.022), and RTOG grade IV morbidity (P = 0.018) were
predicators of major morbidity.
Conclusions: Radiation-induced late morbidity tended to be severe in the RRT group with more patients suffering
RTOG/EORTC grade IV morbidity, while there were no significant differences in postoperative morbidity, mortality and
reoperation. Aggressive resection was feasible with acceptable postoperative outcomes. Severe intra-abdominal adhesion,
ASA grades III–V and RTOG/EORTC grade IV late morbidity contributed significantly to major postoperative morbidity.
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On a global scale cervical cancer is the fourth most com-
mon cancer in women and the seventh overall, with an
estimated 528,000 new cases and 26,000 deaths each year
[1]. Radical hysterectomy and radiotherapy (RT) have long
been mainstays of treatment for cervical cancer. Trad-
itionally, early stage cervical cancer (FIGO stage IB1–IIA)
has been treated with either primary surgery, with or with-
out combined RT, or with definitive RT [2–6]. FIGO stage
IIB-IVA is recognized as a locally advanced cervical cancer
(LACC) and consequentially RT alone or chemoradiother-
apy has been considered as the standard treatment [7, 8].
According to the National Comprehensive Cancer Net-
work (NCCN) guidelines version 2.2015, FIGO stage IB2
and IIA2 are included in the advanced disease category;
cisplatin-based chemoradiotherapy is recommended as
the primary treatment [8].
Despite the improvement in techniques and the avail-
ability of better equipment, chronic radiation enteropathy
(CRE) has remained a major problem in patients undergo-
ing pelvic RT [9]. The reported incidence of late gastro-
intestinal toxicities from RT varies from 8 % to 50 % in
cervical cancer patients [10–12, 3, 13, 14]; some of the pa-
tients with CRE will require surgery to treat obstruction,
fistulas, perforation or bleeding [15].
With progress in perioperative management and surgi-
cal techniques, definitive surgery has gained popularity
as the first choice for patients with CRE [16]. Iraha et al.
[17] retrospectively reviewed 1349 patients with gynae-
cological malignancies who had received radiotherapy
(1132 patients with cervical cancer), and reported that
liberal resection of the affected bowel appears to be the
preferable therapy in patients with radiation enterocoli-
tis. Furthermore, severe radiation enterocolitis requiring
surgery usually occurred at the terminal ileum and is
strongly correlated with previous abdominopelvic surgery,
diabetes mellitus, and smoking [17]. However, there has
been limited information reported, especially regarding
the clinical features and outcome in cervical cancer pa-
tients treated for surgery for CRE in a large cohort study.
The aim of current study was twofold: to describe the
clinical features, postoperative morbidity in cervical can-
cer patients who underwent surgery for CRE; and to iden-
tify possible risk factors for postoperative complications.
Methods
Patients
We retrospectively reviewed the medical records of 196
patients with CRE after pelvic RT for cervical cancer, from
September 2003 to July 2014, in a prospectively main-
tained database at a tertiary-care referral institution. Pa-
tients treated with previous palliative RT (n = 4), and with
tumour recurrence (n = 10) or a pelvic neoplasm (n = 1),
or who underwent nonsurgical treatment (n = 15) wereexcluded from the present study. The diagnosis of CRE
was confirmed by intraoperative findings and postopera-
tive pathology. Finally, 166 eligible patients requiring sur-
gery for CRE were included in the study; 46 patients had
previously received radical radiotherapy (RRT) without gy-
naecological surgery, and 120 patients had received radical
surgery plus RT (RS + RT) for cervical cancer. The cohort
study was approved by the ethics committee of Jinling
Hospital.
Data on the following parameters were extracted from
the patients’ medical records: demographics; FIGO tumour
stage; cumulative dose; latency period between the first
symptoms and completion of RT; time interval from dis-
ease onset to surgery; nutritional status; clinical manifesta-
tions; perioperative parameters; postoperative morbidity;
and mortality. Perioperative parameters including pre-
operative total parenteral nutrition (TPN) dependence,
American Society of Anesthesiologists (ASA) grade, surgi-
cal procedures, operation time and intraperitoneal adhe-
sion states.
Grading criteria
The grading system used for late radiation gastrointes-
tinal morbidity was in accordance with the criteria of
the Radiation Therapy Oncology Group (RTOG) and the
European Organization for Research and Treatment of
Cancer (EORTC), with grade III for obstruction or bleed-
ing requiring surgery, and grade IV for necrosis/perfor-
ation or fistula [18].
The severity of intraperitoneal adhesion was assessed
by the operating surgeons and graded from I to V ac-
cording to the scale that Hobson et al. reported [19].
Patients with no adhesion were defined as grade I. Pa-
tients with moderate adhesion included grade II (min-
imal adhesions localised to one or two areas) and grade
III (diffuse adhesions, but not extensive). Patients with se-
vere adhesion included grade IV (diffuse, extensive adhe-
sions easily lysed) and grade V (diffuse, extensive, dense
adhesions difficult to lyse).
Postoperative morbidity was graded according to the
Clavien–Dindo classification [20]. Postoperative TPN de-
pendence for >2 weeks was considered as grade II mor-
bidity. For patients who underwent staged procedures
(i.e., stoma in the first operation and stoma reversal in
the second operation), the complication rate was calcu-
lated as the total events encountered in two operations.
Follow-up
All patients were followed up until death or July 2014,
when the data were collected. The long-term outcomes,
including TPN dependence, tumour recurrence and reop-
eration for CRE were evaluated. In addition, patient sur-
vival status and the presence of a definite stoma at the end
of follow-up were also recorded by review of the medical
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no regular postoperative outpatient visits for >3 months.
Statistical analysis
Results are presented as the mean ± SD or median (range)
for continuous variables, except for categorical variables
which are presented as numbers. Statistical analysis was
performed using Student’s t test for continuous variables
and Pearson’s chi-square test or Fisher’s exact test for cat-
egorical variables as appropriate. Potential risk factors for
postoperative morbidity were evaluated using univariate
analysis, and risk factors with p < 0.10 were included in
the multivariate analysis using multivariate logistic regres-
sion analysis. Survival status was analysed using the
Kaplan–Meier method and distributions were compared
using the log rank test. Result with p < 0.05 were consid-
ered significant. All analyses were performed using the
Statistical Package for Social Sciences software (version
19.0; SPSS, Inc., Chicago, IL, USA).
Results
Patient characteristics
Patients in the RRT group mostly had LACC, with 92.9 %
of patients staged as IIb–Va; patients in the RS + RT group
had early stage cervical cancer, with 86.7 % of patients
staged as I–IIa. Patients in the RRT group were older
than those in the RS + RT group (51.8 years vs 47.8 years;
p < 0.05). The total radiation dose (external beam plus
brachytherapy) was known for 107 (64.5 %) patients, with a
mean dose of 72.6 Gy and 50.4 Gy in the RRT and RS + RT
groups, respectively. The median latency period from com-
pletion of radiotherapy to disease onset in the RS + RT
group tended to be shorter than in the RRT group
(6 months vs 9 months; p = 0.000). The baseline demo-
graphics are presented in Table 1.
Clinical manifestations
The main clinical manifestation in the present study was
clustered into four broad categories: stenosis/obstruction
(139/166); fistula (15/166); free perforation (5/166); and
severe chronic radiation proctitis (SCRP) (7/166). The
main symptoms of CRE on admission are presented in
Table 2. Considered overall, patients in the RS + RT group
were more likely to present with RTOG/EORTC grade III
late morbidity (obstruction/SCRP) (92.5 % vs 76.1 %;
p = 0.004), while patients in the RRT group tended to
show RTOG/EORTC grade IV late morbidity (fistula/
perforation) (23.9 % vs 7.5 %; p = 0.004). Intestinal or
colorectal stricture responsible for complete or incom-
plete obstruction was the most common symptom with
65.2 % in the RRT group and 90.8 % in the RS + RT
group (p = 0.000). Fistula, the second most common
symptom, was inclined to appear more often in the
RRT group than in the RS + RT group (17.4 % vs 5.8 %;p = 0.020). Although not statistically significant, the inci-
dence of perforation in the RRT group was five times
higher than that in the RS + RT group (6.5 % vs 1.7 %;
p = 0.258). Fourteen (30.4 %) patients in the RRT group and
10 (8.3 %) in the RS + RT group suffered from chronic radi-
ation proctitis, and chronic radiation proctitis was the main
reason for surgery in seven of them.Surgical procedures
Details of the surgical parameters are shown in Table 2. In
the study, 143 patients underwent aggressive resection
procedures; 13 (28.3 %) patients in the RRT group and 10
(8.4 %) patients in RS + RT group merely underwent
ileostomy or colostomy because of poor nutritional status,
severe intraperitoneal adhesion or radiation-induced recto-
sigmoid lesions. The state of intraperitoneal adhesion was
much more severe in the RS + RT group than in the RRT
group in patients who did not receive additional abdom-
inal/pelvic surgery except for primary surgery for cervical
cancer. However, radiation-induced gastrointestinal lesions
were extensive in the RRT group with more patients under-
going colostomy for severe recto-sigmoid disease (32.6 % vs
9.1 %; p = 0.000).Postoperative morbidity
Sixty (36.1 %) patients experienced no adverse events
and recovered uneventfully; however, 29 (63.0 %) in the
RRT group and 77 (64.2 %) in the RS + RT group experi-
enced postoperative morbidity. Major (grades III–V) mor-
bidity was higher in the RRT group than in the RS + RT
group, but did not differ significantly (21.7 % vs 11.7 %;
p = 0.137). Postoperative morbidity according to the
Clavien–Dindo classification is detailed in Table 3. Four
patients died during the postoperative course; one patient
died of uncontrolled intra-abdominal haemorrhage, and
the other three from intra-abdominal sepsis and multiple
organ dysfunction syndrome (MODS). Surgical complica-
tions occurred in 16.3 % of patients (8 in the RRT group
vs 19 in the RS + RT group); among these patients, three
in the RRT group and four in RS + RT group required
relaparotomy.Risk factors for postoperative morbidity
Factors associated with overall and major postoperative
morbidity in univariate and multivariate analysis are listed
in Table 4. In multivariate analysis, preoperative anaemia
(p = 0.015) was found to be a significant predictor for
overall postoperative morbidity, while severe intraperito-
neal adhesion at the surgical site (grades IV–V; p = 0.017),
ASA grades III–V (p = 0.022), RTOG/EORTC grade IV
late morbidity (p = 0.018) were significantly associated
with major morbidity.
Table 1 Demographic data of 166 cervical cancer patients requiring surgery for chronic radiation enteropathy
Characteristics RRT (n = 46) RS + RT (n = 120) P value
Age, y (mean ± SD) 51.8 ± 10.4 47.8 ± 9.4 0.020
Tumor stage, n (%)a 0.000
I-IIa 3(7.1) 78(86.7)
IIB-IVa 39(92.9) 12(13.3)
Cumulative dosage, Gy (mean ± SD)b 72.6 ± 22.0 50.4 ± 13.1 0.000
Preoperative, n (%) - 5 (4.17)
Postoperative, n (%) - 111 (92.5)
Pre/postoperative, n (%) - 4 (3.33)
Chemotherapy, n (%) 26(56.5) 57(47.5) 0.298
Pathological pattern, n (%)c 0.147
squamous carcinoma 40 (90.9) 94 (79.7)
adenocarcinoma 4 (9.1) 14 (20.3)
Acute radiation enteritis, n (%)d 16/38 (42.1 %) 42/112(37.5 %) 0.614
Median latency period, n (%) Median (range), n (%) 9(3–264) 6(3–129) 0.000
≦6 13 (28.3) 70 (58.3) 0.001
7–12 17 (37.0) 33 (27.5) 0.235
13–24 6 (13.0) 7 (5.8) 0.122
>24 10 (21.7) 10 (8.3) 0.018
Time interval from disease onset to referral Median (range) 6.5(1–108) 5.5(0.5–152) 0.295
BMI, mean ± SD (range) N (%) 19.0 ± 3.1 17.8 ± 3.2 0.025
<=18.5 23(50.0) 75(65.8) 0.074
>18.5 23(50.0) 39(34.2) 0.074
hypertension 3 (6.5) 9 (7.5) 1.000
Diabetes mellitus 2(4.3) 2(1.7) 0.658
Double j-tube placement, n (%) 4 (8.7) 1 (0.8) 0.021
Blood infusion, n (%) 9 (19.6) 29 (24.2) 0.528
Previous abdominal surgery, n (%) 21(45.7) 36(30.0) 0.086
RRT Radical Radiotherapy, RS + RT Radical Surgery plus Radiotherapy, SD standard deviation, BMI body mass index
aFIGO tumor stage was unknown in 34 patients (4/30)
bRadiation dose was unknown in 39 patients (11/28)
cPathological pattern was unknown in 14 patients (2/12)
dAcute radiation enteritis was unknown in 16 patients (8/8)
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Mean and median follow-up times were 29 months and
26 (range, 5–70) months, respectively in the RRT group,
and 36 months and 33 (range, 5–121) months in the RS
+ RT group. Seven patients in the RRT group and four in
the RS + RT group died during the follow-up period
(Fig. 1). Of note, seven patients died of MODS caused
by intra-abdominal leakage and sepsis within 3 months
after discharge, while the other patients died of tumour
recurrence at 1 year after discharge. Seven patients ex-
hibited symptoms of recurrence of CRE, and each of two
groups had two patients requiring reoperation. However,
only one patient could not be weaned off TPN because
of short bowel syndrome. By the end of the follow-up
period, a definitive stoma was present in 19 (44.2 %)patients in the RRT group as compared with 15 (12.6 %)
in RS + RT group (p = 0.000).
Discussion
Because the management of cervical cancer is stratified
by tumour stage, we undertook this retrospective study
to analyse the clinical characteristics and postoperative
outcomes for inpatients with CRE requiring surgery after
RRT or RS plus RT. In this series of 166 consecutive
cases of CRE requiring surgery, more patients suffered
from radiation-induced fistula, perforation and proctitis
in the RRT group. An aggressive intestinal resection pro-
cedure was performed in almost all of the cases with
overall and major morbidity rates of 63.9 % and 14.5 %,
respectively. Although the surgical procedure is very
Table 2 Clinical manifestation and surgical parameters of 166 patients requiring surgery for chronic radiation enteropathy
Characteristics RRT (n = 46) RS + RT (n = 120) P value
Surgical procedure, n (%)
Obstruction 30(65.2) 109(90.8) 0.000
Ileal R/A 9(15.2) 41(34.2)
Ileocecal R/A 7(23.3) 39(32.5)
Ileal/Ileocecal R+ ileostomy 8(17.4) 22(18.3)
Ileal/Ileocecal R/A+ colostomy 2(4.3) 1(0.8)
Ileostomy 3(6.5) 2(1.7)
Colostomy -(0) 1(0.8)
Intestinal enterolysis + Intestinal 1(2.2) 0(0)
Intubafion Plicafion
Fistula 8(17.4) 7(5.8) 0.020
Ileal R+ ileostomy 1(2.2) -
Ileal R/A+ colostomy 1(2.2) -
Ileocecal R/A+ colostomy 1(2.2) 3(2.5)
Ileal R+ ileostomy + colostomy 1(2.2) -
Ileal R/A+ neobladder + colostomy 1(2.2) -
Colostomy 3(6.5) 4(3.3)
Free perforation 3(6.5) 2(1.7) 0.258
ileostomy 2(4.3) 2(1.7)
Ileocecal R/A+ colostomy 1(2.2) -
Severe chronic radiation proctitisa 5(10.9) 2(1.7) 0.027
Colostomy 4(8.7) 1(0.8)
Ileocecal R/A+ colostomy 1(2.2) 1(0.8)
Total diversion stomy, n (%) 26(56.5) 36(29.8) 0.001
Ileostomy 16(34.8) 24(20.0) 0.067
Colostomy 15 (32.6) 11 (9.1) 0.000
Intraperitoneal adhesion states, n (%)b
None(I) 12 (41.4) 8 (8.9) 0.000
Moderate(II-III) 12(41.4) 65(72.2) 0.003
Severe(IV-V) 5(17.2) 17(18.9) 0.842
RRT Radical Radiotherapy, RS + RT Radical Surgery plus Radiotherapy, R/A Resection/Anastomosis, R resection
aSevere chronic radiation proctitis as the main clinical manifestation requiring surgery
bIntra-peritoneal adhesion states in patients without suffer other abdominal/pelvic surgery before transferred to our center, except for previous pelvic surgery for
cervical cancer
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diated bowel is suitable and feasible with acceptable
postoperative outcomes.
Radiation induced digestive stenosis, which was respon-
sible for complete or incomplete obstruction, was the
most common symptom and surgical indication (81.9 %);
this finding is consistent with the previous literature [21–
23]. Concerning the site of obstruction, our results indi-
cated that the terminal ileum/ileocecum was the most fre-
quently and severely affected site. Several studies have also
reported similar results [23, 17]. Iraha et al. [17] reported
that 37 out of 48 gynaecological cancer patients developed
radiation induced stenosis requiring surgical management,and found that the terminal ileum, sigmoid and rectum
were the sites of the majority of the radiation-induced le-
sions. The current case series revealed that the incidence
of radiation-induced stenosis in the RS + RT group was
higher than in the RRT group (90.8 vs 65.2 %; p = 0.000).
A possible explanation for the increased incidence of ob-
struction could be the gynaecological surgical procedure
for cervical cancer, during which surgical extirpation of
the uterus or other organs allowed normal bowel fall
within the pelvic radiation field [17]. In addition, postoper-
ative adhesion can affect the normal mobilization of the
intestine, which causes the small bowel loops to be fixed
in the pelvis. The fact that the intestine is more sensitive
Table 3 Postoperative complications according to Clavien-Dino
classification in 166 cervical cancer patients after surgery for
chronic radiation enteropathy
Postoperative complication RRT (n = 46) RS + RT (n = 120) P value
Grade I 5(10.9 %) 21(17.5 %) 0.348
Diarrhea 3 11











Blood transfusion 6 17
Catheter infection 1 7




























Grade IV 2(4.3 %) 1(0.8 %) 0.186







Grade V 3(6.5 %) 1(0.8 %) 0.065
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supply resulting from the surgical procedure might have
aggravated the damage to the irradiated intestinal.
Fistula and SCRP are probably the most severe and
feared late toxicities following RT. As a result of symp-
toms including leaking urine or stools, persistent bleeding,
vulnerability to infection and unbearable pain, patients
may suffer significant physical, social and psychological
distress which negatively impacts on their quality of life[24, 25]. The incidence of radiation-induced fistulas was
estimated as between 1 % and 4 % for all-comers, while
this number can be as high as 22–48 % for more advanced
stages, which is similar to our findings [24, 26]. In the
current series, the incidence of fistula and SCRP (as the
main symptoms of patients who underwent surgery) in
the RRT group was significantly higher than that in the
RS + RT group (17.4 % vs 5.8 % [p = 0.020] and 10.9 % vs
1.7 % [p = 0.027], respectively). The probable reason was
that most patients in the RRT group had advanced stage
disease and received a higher cumulative radiation dose,
which correlated closely with an increased incidence of
late toxicities following RT. Correlations between the radi-
ation dose and the incidence of sequelae have been
reported by many authors [27, 28]. In a review of 1456 pa-
tients with cervical carcinoma (stages IB–IVA) treated
with RT (70–90 Gy), Perez et al. [28] quantified the im-
pact of various dosimetric parameters on the incidence of
significant morbidity. They observed an incidence of
recto-sigmoid morbidity of < 4 % with doses below 75 Gy
and 9 % with higher doses; for the small intestine the inci-
dence of morbidity was < 1 % after a total dose of ≤50 Gy,
2 % after 50–60 Gy and 5 % after higher doses. Previous
series have noted a variety of risk factors for severe late
toxicities, but common predictors tend to include ad-
vancing tumour stage, previous pelvic radiotherapy, the
use of RS, an active smoking habit and elevated RT doses
[29, 11, 26]. The poor wound-healing characteristics that
increase susceptibility to fistula development can largely
be attributed to sclerosis in small and medium sized blood
vessels, relative tissue hypoxia and soft tissue fibrosis that
occurs following RT [25].
Most patients with refractory complications had more
than one radiation-induced late toxicity, which increased
the complexity of the disease [30]. In the current study,
42 patients underwent both ileal/ileocecal resection and
stromal diversion because of radiation-induced multiple
injuries. Turina et al. [30] also reported that over two-
thirds of their patients developed two or more compli-
cations from RT, and many patients required a major
operation with faecal diversion and subsequent restorative
operations as a result of the severity of the RT injuries.
Although not statistically significant, the incidence of
perforation in the RRT group observed in the present
series was five times higher than that in the RS + RT group
(6.5 % vs 1.7 %; p = 0.258); this was probably caused by the
limited number of patients in the present study. We ob-
served that the perforation site was the ileum in all five
cases with abdominal pain as the prominent complaint,
while only one (20 %) patient showed signs of acute peri-
tonitis on physical examination. Yamashita et al. [31] also
reported seven cases of small bowel perforation without
tumour recurrence after pelvic radiotherapy for cervical
cancer, and found that signs of peritonitis were absent in
Fig. 1 Survival states in cervical cancer patients after surgery for chronic radiation enteropathy (n= 162). Seven patients in RRT and four patients in RS + RT
group died during follow-up period. In-hospital deaths were excluded from survival analysis
Table 4 Univariant and multivariant analysis of potential factors associated with postoperative complications
Overall morbidity Major morbidity
(grade I–V) (grade III–V)
Univariant Multivariant Univariant Multivariant
Variables P value P value OR(95 % CI) P value P value OR(95 % CI)
Anemia (Y/N) 0.023 0.015 2.626(1.204–5.728) 0.473 - -
Time interval from disease onset to surgery (<6 m/>6 m) 0.000 0.062 0.527(0.269–1.364) 0.181 - -
Chemotherapy (Y/N) 0.023 0.307 0.7(0.353–1.388) 1.000 - -
Operation time 0.092 0.210 1.588(0.770–3.277) 0.816 - -
(<150/>150) min
Adhesion states in surgical site (IV-V/I-III) 0.046 0.089 2.180(0.887–5.360) 0.066 0.017 3.535(1.250–10.001)
ASA grade (III–V/I-II) 1.000 - - 0.014 0.022 3.400(1.197–9.653)
RTOG/ETORC Grade IV late morbidity (Y/N) 0.129 - - 0.001 0.018 0.171(0.040–0.735)
Stomy surgery (Y/N) 0.617 - - 0.039 0.575 1.723(0.257–11.546)
Staged surgery (I/II) 0.492 - - 0.099 0.735 0.731(0.120–4.474)
Age (<50/>50) y 0.624 - - 1.000 - -
Tumor stage (I-IIa/IIb-V) 0.496 - - 0.702 - -
Pathological type (squamous carcinoma/adenocarcinoma) 0.710 - - 1.000 - –
Radiation dosage (Gy) 0.373 - - 0.379 - -
Acute radiation enteritis (Y/N) 0.475 - - 0.807 - -
Previous abdominal surgery (Y/N) 0.345 - - 0.789 - -
Latency period (m) 0.194 - - 0.369 - -
Hypertention (Y/N) 0.569 - - 0.108 - -
Diabetes mellitus (Y/N) 0.616 - - 0.453 - -
BMI < 18.5 and weight loss >10 % 0.217 - - 1.000 - -
Preoperative TPN (Y/N) 0.407 - - 0.493 - -
Short bowel syndrome (Y/N) 0.330 - - 1.000 - -
RTOG/ETORC the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC), ASA American Society
of Anesthesiologists, BMI Body mass Index
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complaint. The absence of signs of acute peritonitis might
have been attributable to the nature of its histopatho-
logical features, including obliterative endarteritis and pro-
gressive stromal fibrosis in the submucosal/subserosal
layers, which limited inflammation resulting from severe
abdominal adhesion.
Optimal surgical strategies for patients with CRE remain
controversial. Various surgical procedures have been pro-
posed, including aggressive resection/anastomosis, adhe-
siolysis, stoma formation and bypass. According to the
experience from our centre and others [16, 32, 17, 12], the
optimal procedure for CRE is resection and anastomosis,
and the avoidance of bypass or other conservative proce-
dures. If there is severe dense adhesion or poor general
condition, a conservative procedure could be considered as
an alternative option. Aggressive resection of the radiation-
induced lesions, if possible, would improve the long-term
outcomes after surgery. Lefevre et al. [21] demonstrated
the importance of resecting all damaged tissue in patients
with CRE, and reported that as compared with bypass or
adhesiolysis, ileocecal resection was the only factor that
protected against reoperation for recurrence.
In the present study, 140 (84.6 %) patients received an
aggressive resection procedure (57.8 % with anastomosis
and 26.5 % with ileostomy/colostomy) with surgical com-
plications in 16.3 % and reoperation in 4.2 % of patients.
Overall and major postoperative morbidity, mortality
and the incidence of reoperation in the two groups did
not differ significantly. According to the updated Clavien–
Dindo classification [20], overall postoperative morbidity
and major (grades III–V) morbidity were observed in
63.8 % and 14.5 % of patients, respectively. Postoperative
mortality was 2.4 % and incidence of reoperation was
4.8 %, which is comparable or lower than in previous re-
ported series [33, 21]. Lefevre et al. [21] analysed 107 pa-
tients after extensive resection surgery for CRE and
reported that the overall morbidity, surgical morbidity and
postoperative mortality were 74.8 %, 28.0 % and 0.9 %, re-
spectively. An earlier study by Regimbeau et al. [33]
reported that postoperative surgical complications and
mortality were 29 % and 5 %, respectively; anastomotic
leakage occurred in 9 % of patients after aggressive surgery
for CRE. Most patients in the present study experienced a
planned procedure and nutritional support before surgery;
this might have partly contributed to the decreased post-
operative morbidity. In addition, nearly two-thirds of pa-
tients were operated in recent three years and given a
targeted intervention following a detailed clinical algorithm,
which could also have effectively improved outcomes.
During follow-up, mortality in the RRT group was sig-
nificantly higher than that in the RS + RT group; seven pa-
tients died of MODS caused by intra-abdominal leakage
or sepsis and four as a result of tumour recurrence. Ofnote, death secondary to postoperative complications usu-
ally occurred within 3 months after discharge, while pa-
tients with tumour recurrence tend to died 1 year later.
Therefore, we believed that the focus should be on post-
operative complications during the first 3 months after
treatment, and then be transferred to tumour monitoring.
In addition, the high incidence of permanent stoma in the
RRT group might be demonstrated by the higher inci-
dence of fistula and SCRP as a result of escalation of the
radiation dose and advanced tumour stage. Because a fis-
tula occurring in irradiated tissue can rarely be success-
fully repaired, most surgical treatments are palliative in
the form of faecal or urinary diversion, leaving patients
with a permanent colostomy or ileostomy [25].
The current study also analysed the risk factors associ-
ated with overall and major postoperative morbidity. In
particular, severe intraperitoneal adhesion was signifi-
cantly associated with major morbidity, which has also
been identified in various previous studies [34, 35]. RT
delivered to the pelvic/abdominal region could contrib-
ute to the formation of adhesions and fibrosis, perhaps
as a result of vascular damage, which could cause sten-
osis, fistula and even death [35]. Furthermore, adhesions
make subsequently intraperitoneal operations more diffi-
cult, and put the patient at higher risk for complications,
such as enterotomy, fistula or injury to other intraperito-
neal organs.
In multivariate analysis, preoperative anaemia was
found to contribute significantly to overall postoperative
morbidity, while ASA grades III–V, severe intraperitoneal
adhesion and RTOG/EORTC grade V morbidity were sig-
nificantly associated with major morbidity. Other predis-
posing factors associated with postoperative morbidity
include diabetes mellitus, smoking, hypertension, previous
abdominal surgery, concurrent chemotherapy and cumu-
lative dosage, which have been reported in previously
studies; however, we did not identify a significant correl-
ation between these parameters and morbidity, probably
because the limited number of patients enrolled in our
study.
The present study had a number of limitations beyond
its retrospective bias. It involved a single-institution sam-
ple at a tertiary-care referral centre. The true prevalence
of CRE requiring surgery in cervical cancer patients re-
mains unknown because of the paucity of prospective
population studies. In addition, patients in the RRT group
tended to be older, in worse condition and necessitated a
far higher total radiation dose, which could be a con-
founding factor. However, the key objective of our study
was to analyse the characteristics of CRE patients after they
had received two treatment modalities (RRT vs RS + RT)
for cervical cancer. The study was not novel but is of clin-
ical importance and interest for clinicians regarding the
evaluation of the disease course and prognosis.
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Radiation-induced late morbidity tended to be more
severe in the RRT group, with more patients suffering
from RTOG/EORTC grade IV morbidity. Although there
were no significant differences in postoperative morbid-
ity, mortality and rate of reoperation, more patients in
the RRT group will inevitably suffer from a permanent
stoma. Aggressive resection was feasible in dealing with
late morbidities induced by pelvic RT and could be
adopted with acceptable levels of surgical complications
and postoperative mortality. Severe intra-abdominal ad-
hesion, ASA grades III–V and RTOG grade IV morbidity
were found to be predicators of major morbidity.
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